An easy to give oral liquid containing meloxicam for the alleviation of pain & inflammation.
An easy to give oral liquid containing meloxicam.
- Sweet tasting formulation maximises ease of administration
- Licensed for the treatment of musculo-skeletal disorders and the alleviation of post-operative pain
Available in 15ml bottles containing 0.5mg/ml meloxicam
- Maintenance dose is 0.05mg meloxicam/kg bodyweight
- Tailored maintenance dosing syringe with a “kg scale” for all sizes of cat
- On the first day, a loading dose of twice the maintenance dose should be given
- 6 months shelf-life once opened
*To nearest day on maintenance dose.
Clinical signs of osteoarthritis in the cat
Reduced activity levels
Reduced interaction with the owner
Affected cats may:
Overt lameness is often not present, but
clinical signs may include:
MELOXIDYL 0.5 mg/ml Oral Suspension for Cats: Each ml contains 0.5 mg meloxicam.
Alleviation of inflammation and pain in chronic musculo-skeletal disorders in cats. Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Contraindications: Do not use in pregnant or lactating animals. Do not use in cats suffering
from gastrointestinal disorders such as irritation and haemorrhage, impaired hepatic, cardiac or renal functionand haemorrhagic disorders. Do not use in case of hypersensitivity to the active substance or to any of the excipients. Do not use in cats less than 6 weeks of age. Adverse reactions: Typical adverse reactions of NSAIDs such as loss of appetite, vomiting, diarrhoea, faecal occult blood, apathy and renal failure have occasionally been reported. These side effects are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Precautions: Special precautions for use in animals: If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.Avoid use in any dehydrated, hypovolaemic or hypotensive animal, as there is a potential risk of renal toxicity. Response to long-term therapy should be monitored at regular intervals by a veterinary surgeon. MELOXIDYL 0.5 mg/ml oral suspension for cats should not be used following parenteral injection of meloxicam or any other non-steroidal anti-inflammatory drugs (NSAIDs) as appropriate dosage regimens for such follow-up treatments have not been established in cats. The safety of the veterinary medicinal product has not been established during pregnancy and lactation.
Special precautions to be taken by the person administering the product:
People with known hypersensitivity to NSAIDs should avoid contact with the veterinary medicinal product. In case of accidental ingestion, seek medical advice immediately and show the package leaflet or the label to the physician. Interactions: Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects. MELOXIDYL must not be administered in conjunction with other NSAIDs or glucocorticosteroids. Concurrent administration of potential nephrotoxic drugs should be avoided. Pre-treatment with anti-inflammatory substances may result in additional or increased
adverse effects and accordingly a treatment-free period with such drugs should be observed for at least 24hours before commencement of treatment. The treatment-free period, however, should take into account the pharmacological properties of the products used previously.